---
$id: https://graph.org.ai/products/commodity/51112708
$type: Product
source: UNSPSC
code: "51112708"
title: "Picoplatin"
class: "51112700"
classTitle: "Alkylating agent organoplatinum compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Picoplatin

**UNSPSC Code**: 51112708
**Class**: [Alkylating agent organoplatinum compounds](Alkylating agent organoplatinum compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a platinum compound with the molecular structure C6H7N.2CL.PT.H3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, B5TAN0L720 chemically known as platinum, amminedichloro(2-methylpyridine)-, (sp-4-3)-, but more commonly known as picoplatin, which bears US NIH Compound Identifier 177358. European Medicines Agency schedules Picoplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29605. The term PICOPLATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49). Picoplatin bears US NLM identifiers UMLS ID C0671135 and NCI Concept Code C48416. Most nations, for tariff and trade purposes, schedule picoplatin under HS 28439000 and SITC 52432. SMILES: CC1CCCCN1.N.[CL-].[CL-].[PT+2].

